| Literature DB >> 35733173 |
Xiang Kong1, Peng Ruan2, Jiquan Yu2, Hui Jiang2, Tianshu Chu2, Jianjun Ge3.
Abstract
BACKGROUND: This study aimed to investigate the safety of direct innominate arterial (IA) cannulation using a pediatric arterial cannula to establish selective antegrade cerebral perfusion (ACP) during total arch replacement (TAR) for acute Stanford type A aortic dissection (ATAAD).Entities:
Keywords: Aortic arch; Aortic dissection; Cerebral perfusion; Direct innominate cannulation
Mesh:
Year: 2022 PMID: 35733173 PMCID: PMC9219173 DOI: 10.1186/s13019-022-01919-2
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.522
Fig. 2A The innominate vein was isolated and pulled caudally and the innominate artery (IA) was dissected. B A 14F or 16F pediatric arterial cannula was inserted directly into the IA in the direction of the right common carotid artery and secured with purse-string sutures. C The cannula was placed in the vessel at a depth of 4 cm to ensure that the proximal end was inserted into the right common carotid artery
Fig. 1The 14F pediatric arterial cannula used for cannulating the innominate artery to enable antegrade cerebral perfusion
Preoperative patient characteristics
| Variable | Value |
|---|---|
| Age, years (mean ± SD) | 50.9 ± 9.47 |
| Male sex, n (%) | 24 (82.8) |
| BMI, kg/m2 (mean ± SD) | 26.5 ± 3.48 |
| Smoker, n (%) | 13 (44.8) |
| Hypertension, n (%) | 25 (86.2) |
| Family history of heart or aortic disease, n (%) | 1 (3.4) |
| Previous myocardial infarction, n (%) | 2 (6.9) |
| Largest aortic diameter by CT, mm (mean ± SD) | 45.0 ± 7.01 |
| Recent stroke, n (%) | 2 (6.9) |
| Chronic lung disease, n (%) | 3 (10.3) |
| Renal failure, n (%) | 1 (3.4) |
| Marfan syndrome, n (%) | 1 (3.4) |
Data are presented as mean ± standard deviation or n (%)
BMI, body mass index; CT, computed tomography; SD, standard deviation
Operative data
| Variable | Value |
|---|---|
| Proximal aortic reconstruction | |
| Aortic root plasty, n (%) | 27 (93.1) |
| Bentall procedure, n (%) | 2 (6.9) |
| Concomitant procedures | |
| CABG, n (%) | 2 (6.9) |
| CPB time, min (mean ± SD) | 202 ± 29 |
| Cross-clamp time, min (mean ± SD) | 141 ± 28 |
| ACP time, min (mean ± SD) | 25 ± 6.4 |
| Lowest nasopharyngeal temperature, °C (mean ± SD) | 23.8 ± 0.74 |
Data are presented as mean ± standard deviation or n(%)
ACP, antegrade cerebral perfusion; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; SD, standard deviation
Perioperative outcomes
| Variable | Value |
|---|---|
| Re-exploration for surgical bleeding, n (%) | 1 (3.4) |
| Perioperative myocardial infarction, n (%) | 1 (3.4) |
| New renal failure requiring dialysis, n (%) | 0 (0) |
| Ventilation, h (mean ± SD) | 54 ± 35.3 |
| Pulmonary complication, n (%) | 11 (37.9) |
| Tracheostomy, n (%) | 0 (0) |
| ICU stay, h (mean ± SD) | 129 ± 59 |
| Stroke, n (%) | 2 (6.9) |
| Delirium, n (%) | 4 (13.8) |
| Multi-system organ failure, n (%) | 1 (3.4) |
| Limb ischemia, n (%) | 1 (3.4) |
| Paraplegia, n (%) | 3 (10.3) |
| Deep sternal wound infection, n (%) | 1 (3.4) |
| 30-day/in-hospital mortality, n (%) | 1 (3.4) |
Data are presented as mean ± standard deviation or n (%)
ICU, intensive care unit; SD, standard deviation